Sepsis associated disseminated intravascular coagulation research hub

A first in human single dose escalation study to investigate the safety, tolerability, pharmacokinetics, and pharmcodynamics of BAY 3389934 compared with placebo.

This study is testing a new medicine called BAY 3389934 for the first time in people. It's for a serious condition called sepsis-related DIC, which causes blood clotting problems. Doctors want to see if it's safe, how the body handles it, and what effects it has.